STOCK TITAN
  1. Home
  2. Sec-filings
  3. BSVN
  4. [Form 4] Bank7 Corp. Insider Trading Activity

Bank7 Corp. (BSVN) exec sells 5,049 shares after option exercise

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Bank7 Corp. executive Jason E. Estes, Exec. Vice President and Chief Credit Officer, reported a series of July 2026 equity transactions. On July 21, he exercised 1,250 employee stock options for common stock at an exercise price of $14.3100 per share and received the same number of common shares. He then sold 1,250 and 1,975 common shares at $49.2000 and $49.7000 per share, respectively, followed by a July 22 open-market sale of 1,824 common shares at a weighted-average price of $48.2516, with individual trades ranging from $48.25 to $49.75. The option exercise relates to a grant of 5,000 employee stock options that vested between 2022 and 2025, and current reported holdings include multiple restricted stock unit awards (2,047; 30,000; 4,035; and 2,549 units) with vesting dates from 2025 through 2033. These transactions were not reported as made under a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider Estes Jason E
Role Exec. Vice President; CCO
Sold 5,049 shs ($248K)
Approx. gross sale proceeds $248K
Approx. exercise cost $18K
Type Security Shares Price Value
Sale Common stock, par value $0.01 per share F1, F2, F3, F4, F5 1,824 $48.2516 $88K
Exercise Employee Stock Options F6 1,250 $0.00 $0.00
Exercise Common stock, par value $0.01 per share F2, F3, F4, F5 1,250 $14.31 $18K
Sale Common stock, par value $0.01 per share F2, F3, F4, F5 1,250 $49.20 $62K
Sale Common stock, par value $0.01 per share F2, F3, F4, F5 1,975 $49.70 $98K
Holdings After Transaction: Employee Stock Options — 0 shares (Direct); Common stock, par value $0.01 per share — 100,074 shares (Direct)
Footnotes (6)
  1. F1. The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $48.25 to $49.75. Upon request, the reporting person will provide the SEC, the company, or any stockholder full information regarding the number of shares sold at each separate price in the range.
  2. F2. Includes 2,047 restricted stock units that vest in three equal installments on July 29, 2026, 2027, and 2028.
  3. F3. Includes 30,000 restricted stock units that vest in eight equal installments on July 29, 2026, 2027, 2028, 2029, 2030, 2031, 2032, and 2033.
  4. F4. Includes 4,035 restricted stock units. The original grant of 6,052 restricted stock units vests in three equal installments on February 15, 2026, 2027, and 2028.
  5. F5. Includes 2,549 restricted stock units. The original grant of 7,647 restricted stock units vests in three equal installments on February 15, 2025, 2026, and 2027.
  6. F6. Represents a grant of 5,000 employee stock options that vested in four equal installments on January 4, 2022, 2023, 2024, and 2025.
Total common shares sold 5049 shares Aggregate Bank7 common stock sales reported for July 21–22, 2026
Options exercised 1250 shares Employee stock options for common stock exercised on 2026-07-21 at $14.3100
Sale price per share 49.2000 Price for sale of 1250 common shares on 2026-07-21
Sale price per share 49.7000 Price for sale of 1975 common shares on 2026-07-21
Weighted-average sale price 48.2516 Weighted-average price for sale of 1824 common shares on 2026-07-22, range $48.25–$49.75
Restricted stock units grant 30000 units RSUs vesting in eight equal installments from July 29, 2026 through July 29, 2033
Restricted stock units grant 2047 units RSUs vesting in three equal installments on July 29, 2026, 2027, and 2028
restricted stock units financial
"Includes 2,047 restricted stock units that vest in three equal installments"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
employee stock options financial
"Represents a grant of 5,000 employee stock options that vested in four equal installments"
Employee stock options are contracts that give workers the right to buy a company's shares at a set price sometime in the future, like a coupon that lets you purchase stock at today’s price later on. Investors care because they align employees’ incentives with company performance and create a potential future claim on shares that can reduce existing owners’ percentage and add to a company’s reported compensation costs.
weighted average financial
"The price reported is a weighted average. The shares were sold in multiple transactions"
A weighted average is a way of calculating an overall number when some items matter more than others by giving each item a different level of importance, or weight. Investors use weighted averages to combine figures like prices, returns or earnings so the result reflects the size or significance of each part — like grading a class where a final exam counts more than a quiz, producing a score that better represents true performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What did Bank7 Corp. (BSVN) executive Jason Estes report in this Form 4?
Jason E. Estes reported an exercise of 1,250 stock options at $14.3100 per share and sales totaling 5,049 common shares in open-market transactions on July 21–22, 2026, at prices around the high $40s per share.

How many Bank7 Corp. (BSVN) shares did Jason Estes sell and at what prices?
Jason Estes sold a total of 5,049 common shares: 1,250 at $49.2000, 1,975 at $49.7000, and 1,824 at a weighted-average price of $48.2516, with trades ranging from $48.25 to $49.75.

What stock options did Jason Estes exercise in Bank7 Corp. (BSVN)?
He exercised 1,250 employee stock options for Bank7 common stock at an exercise price of $14.3100 per share. These options are part of a 5,000-option grant that vested in four equal installments between January 4, 2022 and January 4, 2025.

Does the Bank7 Corp. (BSVN) Form 4 indicate a Rule 10b5-1 trading plan?
The Form 4 indicates the trades were not made pursuant to a Rule 10b5-1 plan, as the applicable checkbox is not marked. The filing provides no alternative trading arrangement governing the timing of these transactions.

What restricted stock units does Jason Estes hold in Bank7 Corp. (BSVN)?
Reported holdings include 2,047 restricted stock units vesting in three installments from July 29, 2026–2028; 30,000 units vesting in eight installments from 2026–2033; 4,035 units vesting February 15, 2026–2028; and 2,549 units from a February 15, 2025–2027 grant.

What role does Jason Estes hold at Bank7 Corp. (BSVN)?
Jason E. Estes is reported as an Executive Vice President and Chief Credit Officer of Bank7 Corp. The Form 4 reflects his personal transactions in Bank7 common stock and employee stock options during July 2026.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Estes Jason E
(Last)(First)(Middle)
1039 NW 63RD STREET
(Street)
OKLAHOMA CITY OKLAHOMA 73116
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Bank7 Corp. [ BSVN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Exec. Vice President; CCO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/21/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock, par value $0.01 per share07/21/2026M1,250A$14.31105,123(2)(3)(4)(5)D
Common stock, par value $0.01 per share07/21/2026S1,250D$49.2103,873(2)(3)(4)(5)D
Common stock, par value $0.01 per share07/21/2026S1,975D$49.7101,898(2)(3)(4)(5)D
Common stock, par value $0.01 per share07/22/2026S1,824D$48.2516(1)100,074(2)(3)(4)(5)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Options$14.3107/21/2026M1,250 (6)01/04/2031Common stock1,250$00D
Explanation of Responses:
1. The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $48.25 to $49.75. Upon request, the reporting person will provide the SEC, the company, or any stockholder full information regarding the number of shares sold at each separate price in the range.
2. Includes 2,047 restricted stock units that vest in three equal installments on July 29, 2026, 2027, and 2028.
3. Includes 30,000 restricted stock units that vest in eight equal installments on July 29, 2026, 2027, 2028, 2029, 2030, 2031, 2032, and 2033.
4. Includes 4,035 restricted stock units. The original grant of 6,052 restricted stock units vests in three equal installments on February 15, 2026, 2027, and 2028.
5. Includes 2,549 restricted stock units. The original grant of 7,647 restricted stock units vests in three equal installments on February 15, 2025, 2026, and 2027.
6. Represents a grant of 5,000 employee stock options that vested in four equal installments on January 4, 2022, 2023, 2024, and 2025.
John T. Phillips, Attorney-In-Fact07/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR